Is Celldex Therapeutics (NASDAQ:CLDX) The Next TG Therapeutics Inc (NASDAQ:TGTX) Stock

Prior to this week, TG Therapeutics (NASDAQ:TGTX) and TGTX stock looks a lot like Celldex Therapeutics (NASDAQ:CLDX) or CLDX stock.

Posted in Biotech Hunter, Healthcare & Biotech, Members | Tagged , , , | Leave a comment

Is Celldex Therapeutics (CLDX) Stock the Next Clovis Oncology (CLVS)?

Will Celldex Therapeutics succeed with Glembatumab vedotin at treating triple negative breast cancer patients to make CLDX stock the next CLVS stock?

Posted in Biotech Hunter, Healthcare & Biotech, Members | Tagged , , , | 1 Comment

7 Laggards That Are Bargains In 2017: SHLD, GNC, CLDX, HBI, ALXN

Sears (SHLD), Noodles (NDLS), Celldex Therapeutics (CLDX), Hanesbrands (HBI), CPI Card (PMTS), GNC, & Alexion (ALXN) are laggards with turnaround potential.

Posted in Members, Portfolio Strategy, Timely Analysis | Tagged , , , , , , , , , , , , , | 1 Comment

Celldex Therapeutics, Inc: Why CLDX Stock Could Shock Investors In 2017

Celldex stock loss is the result of Rintega, but Glenbatumaumab, or CDX-011 is what pushed CLDX stock higher before. It could happen again.

Posted in Healthcare & Biotech | Tagged , | Leave a comment

RAD Stock: Walgreens-Rite Aid Merger Shines Doubt

RAD stock performance does not reflect the near-term Rite Aid buyout, and while the Walgreens-Rite Aid merger looks like a sure thing, investors need to remember CLDX stock when considering “sure things” in the market.

Posted in Healthcare & Biotech, Mergers & Acquisitions | Tagged , , , , , | Leave a comment